Artivion, Inc. (AORT)
25.57
-0.05
(-0.20%)
USD |
NYSE |
Sep 04, 16:00
25.55
-0.02
(-0.08%)
After-Hours: 20:00
Artivion Research and Development Expense (Quarterly) : 9.055M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.055M |
| March 31, 2026 | 8.841M |
| December 31, 2025 | 9.122M |
| September 30, 2025 | 8.078M |
| June 30, 2025 | 7.063M |
| March 31, 2025 | 6.728M |
| December 31, 2024 | 7.404M |
| September 30, 2024 | 6.605M |
| June 30, 2024 | 7.497M |
| March 31, 2024 | 6.946M |
| December 31, 2023 | 7.645M |
| September 30, 2023 | 6.421M |
| June 30, 2023 | 7.418M |
| March 31, 2023 | 7.223M |
| December 31, 2022 | 8.304M |
| September 30, 2022 | 11.80M |
| June 30, 2022 | 8.648M |
| March 31, 2022 | 10.13M |
| December 31, 2021 | 9.46M |
| September 30, 2021 | 9.972M |
| June 30, 2021 | 8.36M |
| March 31, 2021 | 7.754M |
| December 31, 2020 | 6.574M |
| September 30, 2020 | 5.755M |
| June 30, 2020 | 5.522M |
| Date | Value |
|---|---|
| March 31, 2020 | 6.356M |
| December 31, 2019 | 5.312M |
| September 30, 2019 | 6.259M |
| June 30, 2019 | 5.841M |
| March 31, 2019 | 5.548M |
| December 31, 2018 | 6.784M |
| September 30, 2018 | 5.225M |
| June 30, 2018 | 5.719M |
| March 31, 2018 | 5.37M |
| December 31, 2017 | 6.363M |
| September 30, 2017 | 4.277M |
| June 30, 2017 | 4.728M |
| March 31, 2017 | 4.093M |
| December 31, 2016 | 3.844M |
| September 30, 2016 | 3.714M |
| June 30, 2016 | 3.279M |
| March 31, 2016 | 2.609M |
| December 31, 2015 | 2.54M |
| September 30, 2015 | 2.96M |
| June 30, 2015 | 2.684M |
| March 31, 2015 | 2.252M |
| December 31, 2014 | 2.092M |
| September 30, 2014 | 1.902M |
| June 30, 2014 | 2.203M |
| March 31, 2014 | 2.502M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Alphatec Holdings, Inc. | 18.17M |
| Globus Medical, Inc. | 36.32M |
| Glaukos Corp. | 51.30M |
| TransMedics Group, Inc. | 31.63M |
| PROCEPT BioRobotics Corp. | 20.10M |